Genes (BAALC, IGFBP7) associated with a stem cell signature and adverse outcome in T-ALL, and typically expressed in myeloid leukemia (WT1, MN1), are highly overexpressed in ETP-ALL (Fig. 2) [33]. This evidence concerns the gene IGFBP7 and acute lymphoblastic leukemia.